Protection of intracellular dopamine cytotoxicity by dopamine disposition and metabolism factors (Q40809060)

23 September 2017

Protection of intracellular dopamine cytotoxicity by dopamine disposition and metabolism factors (English)

1 reference

23 September 2017

0 references

0 references

Weingarten P

1

1 reference

PubMed ID

11331406

23 September 2017

Zhou QY

series ordinal

2

1 reference

PubMed ID

11331406

23 September 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

Journal of Neurochemistry

23 September 2017

1 reference

23 September 2017

77

1 reference

23 September 2017

3

1 reference

23 September 2017

776-785

1 reference

Monoamine oxidase A and B from human liver and brain.

23 September 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Dopamine neurotoxicity in cortical neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Dopamine Neurotoxicity: Inhibition of Mitochondrial Respiration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Free radicals and the pathobiology of brain dopamine systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

The free radical hypothesis in idiopathic parkinsonism: evidence against it

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

An investigation of the assay of dopamine using trinitrobenzensulphonic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Transfection of a 4-hydroxynonenal metabolizing glutathione S-transferase isozyme, mouse GSTA4-4, confers doxorubicin resistance to Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Parkinson's disease: a case-control study of occupational and environmental risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Reduced levels of catalase activity potentiate MPP+-induced toxicity: comparison between MN9D cells and CHO cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Dopamine and glutamate neurotoxicity in cultured chick telencephali cells: effects of NMDA antagonists, antioxidants and MAO inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

The role of vesicular transport proteins in synaptic transmission and neural degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Enzyme activity of macrophage migration inhibitory factor toward oxidized catecholamines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Dopamine transporters and neuronal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Neurotoxicity of endogenous cysteinylcatechols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Presence of macrophage migration inhibitory factor (MIF) in ependyma, astrocytes and neurons in the bovine brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Etiology and pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Monoamine oxidase: from genes to behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Evidence for non-oxidative dopamine cytotoxicity: potent activation of NF-kappa B and lack of protection by anti-oxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Detoxication enzymes and chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00263.X

10.1046/J.1471-4159.2001.00263.X

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference

PubMed ID

11331406